Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-17
DOI
10.1038/s41467-022-30908-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- External Control Arms in Oncology: Current Use and Future Directions
- (2022) P.S. Mishra-Kalyani et al. ANNALS OF ONCOLOGY
- Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States
- (2021) Lisa M. Hess et al. BMC CANCER
- Immunotherapy in non-small cell lung cancer harbouring driver mutations
- (2021) Alfredo Addeo et al. CANCER TREATMENT REVIEWS
- Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
- (2021) Justin F Gainor et al. LANCET ONCOLOGY
- UniPortal thoracoscopic pneumonectomy does not compromise perioperative and long-term survival in patients with NSCLC: A retrospective, multicenter, and propensity score matching study
- (2021) Jiani Gao et al. LUNG CANCER
- Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
- (2021) Vivek Subbiah et al. Lancet Diabetes & Endocrinology
- RET Inhibitors in Non-Small-Cell Lung Cancer
- (2021) Priscilla Cascetta et al. Cancers
- Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small-cell lung cancer
- (2021) Grace G Hsu et al. Immunotherapy
- Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database
- (2021) Andrea De Giglio et al. LUNG CANCER
- The use of nonrandomized evidence to estimate treatment effects in health technology assessment
- (2021) Seamus Kent et al. Journal of Comparative Effectiveness Research
- Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data
- (2021) Samantha Wilkinson et al. JAMA Network Open
- Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies
- (2019) Sebastien Haneuse et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- KIF5B-RET fusion gene and its correlation with clinicopathological and prognosis features in lung cancer: a meta-analysis
- (2019) Xiao-Feng Cong et al. OncoTargets and Therapy
- Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis
- (2018) Shuaishuai Chen et al. CLINICA CHIMICA ACTA
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
- (2018) Rui Zhang et al. Cancer Medicine
- On a Square-Root Transformation of the Odds Ratio for a Common Outcome
- (2017) Tyler J. VanderWeele EPIDEMIOLOGY
- Development and validation of a real-world clinicogenomic database.
- (2017) Gaurav Singal et al. JOURNAL OF CLINICAL ONCOLOGY
- Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non–Small Cell Lung Cancer: A Propensity Score Matching Study
- (2017) Hiroyuki Adachi et al. Journal of Thoracic Oncology
- Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
- (2017) David M. Phillippo et al. MEDICAL DECISION MAKING
- Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis
- (2016) Tomoyuki Hishida et al. Journal of Thoracic Oncology
- Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma
- (2016) Zhengbo Song et al. LUNG CANCER
- A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis
- (2016) Andrew Chiang et al. RADIOTHERAPY AND ONCOLOGY
- Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: Results from propensity score analysis
- (2015) Sahar Mokhles et al. LUNG CANCER
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- Propensity scores: From naïve enthusiasm to intuitive understanding
- (2011) Elizabeth Williamson et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research
- (2009) Peter C. Austin COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now